Merck opened the first M Lab™ Collaboration Center in Europe in March of 2019. Located in Molsheim, France, the facility provides biopharmaceutical customers with a shared, exploratory environment where they can work with Merck scientists and engineers to accelerate the manufacture of new therapies. The 43,000-sf facility offers advanced simulation technologies in a non-GMP environment for end-to-end process development from pre-clinical through full-scale production. The $11.5 million project features pilot and bench scale labs with real equipment as well as conference and meeting areas. The facility will also accommodate bioprocessing training courses. Other M Lab™ Collaboration Centers are located in the United States, Brazil, China, South Korea, Singapore, Japan, and India.
